Spots Global Cancer Trial Database for malignant solid neoplasm

Every month we try and update this database with for malignant solid neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics	NCT04905082	Breast Carcinom... Colorectal Carc... Lung Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin...	Best Practice Educational Int... Educational Int... Genomic Profile Survey Administ...	18 Years -	City of Hope Medical Center
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program	NCT01772771	Glioma Hematopoietic a... Malignant Solid... Melanoma Sarcoma	Biospecimen Col... Genetic Testing Medical Chart R...	-	M.D. Anderson Cancer Center
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)	NCT06351371	Malignant Solid...	Biopsy Biospecimen Col... Computed Tomogr... Erdafitinib Magnetic Resona...	18 Years -	National Cancer Institute (NCI)
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery	NCT04955808	Breast Carcinom... Colon Carcinoma Invasive Carcin... Kidney Carcinom... Liver Carcinoma Malignant Solid... Multiple Myelom... Prostate Carcin...	Biospecimen Col... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials	NCT04650178	COVID-19 Infect... Hematopoietic a... Malignant Solid... Neuropathy	Quality-of-Life... Questionnaire A...	-	M.D. Anderson Cancer Center
Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)	NCT05178472	Hematopoietic a... Malignant Solid... Metastatic Mali...	Immunotherapy Stereotactic Ra... Vertebroplasty	18 Years -	Ohio State University Comprehensive Cancer Center
NCI COVID-19 in Cancer Patients, NCCAPS Study	NCT04387656	COVID-19 Infect... Hematopoietic a... Malignant Solid... Metastatic Mali...	Biospecimen Col... Data Collection Quality-of-Life... Questionnaire A...	-	National Cancer Institute (NCI)
Examining Arts as Therapy in Children With Cancer, CREATe Trial	NCT06342453	Hematopoietic a... Malignant Solid...	Art Therapy Discussion Media Intervent... Survey Administ...	8 Years - 13 Years	OHSU Knight Cancer Institute
A Collaborative Pain Management Intervention for Improving Cancer Pain Management in Rural and Hispanic Cancer Survivors	NCT06198010	Hematopoietic a... Malignant Solid...	Best Practice Educational Int... Questionnaire A... Electronic Heal... Health Telemoni... Cancer Pain Man...	18 Years -	Mayo Clinic
Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome	NCT04745910	Hematopoietic a... Malignant Solid... Tumor Lysis Syn...	Pegloticase Rasburicase	18 Years -	M.D. Anderson Cancer Center
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment	NCT06279013	Hematopoietic a... Malignant Solid...	Counseling Health Educatio... Interview Medical Chart R... Monitoring Questionnaire A...	18 Years -	NRG Oncology
Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology	NCT05496972	Hematopoietic a... Malignant Solid...	Survey Administ...	18 Years -	M.D. Anderson Cancer Center
Transcutaneous Sensors for the Detection of Cancer-Related Lymphedema, Project Limb Rescue Study	NCT06305884	Hematopoietic a... Lymphedema Malignant Solid...	Bioelectric Imp... Exercise Photoplethysmog... Questionnaire A...	18 Years - 90 Years	Ohio State University Comprehensive Cancer Center
Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors	NCT04754529	Hematopoietic a... Malignant Solid...	Quality-of-Life... Survey Administ... Yoga	18 Years -	Roswell Park Cancer Institute
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction	NCT06306638	Malignant Solid...	Biospecimen Col... Computed Tomogr... Endobronchial U... Interstitial Ph... Palliative Radi... Physical Perfor... Questionnaire A... Verteporfin	18 Years -	Roswell Park Cancer Institute
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer	NCT03816345	Autoimmune Dise... Crohn Disease Dermatomyositis Hematopoietic a... Inflammatory Bo... Malignant Solid... Multiple Sclero... Psoriasis Psoriatic Arthr... Rheumatoid Arth... Sjogren Syndrom... Systemic Lupus ... Systemic Sclero... Ulcerative Coli...	Biospecimen Col... Nivolumab	18 Years -	National Cancer Institute (NCI)
Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors	NCT03878095	Malignant Solid... Refractory Chol... Refractory Mali...	Biopsy Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Ceralasertib Computed Tomogr... Magnetic Resona... Olaparib	18 Years -	National Cancer Institute (NCI)
Qualitative Techniques to Define Meaningful Within-Patient Change in Symptoms of Advanced Cancer Patients	NCT06104657	Hematopoietic a... Malignant Solid...	Non-Interventio...	18 Years -	Mayo Clinic
Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study	NCT04803630	Hematopoietic a... Malignant Solid...	Quality-of-Life... Questionnaire A... Thermotherapy	18 Years -	Roswell Park Cancer Institute
Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Chemotherapy	NCT04829539	Hematopoietic a... Malignant Solid...	Behavioral Inte... Behavioral Inte... Quality-of-Life... Questionnaire A...	18 Years -	University of Rochester
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients	NCT06015932	Hematopoietic a... Malignant Solid...	Cognitive Behav... Questionnaire A...	18 Years -	Mayo Clinic
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines	NCT02962661	Cardiomyopathy Heart Failure Hematopoietic a... Malignant Solid...	Best Practice Laboratory Biom... Mesenchymal Ste... Mesenchymal Ste...	18 Years - 80 Years	M.D. Anderson Cancer Center
Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment	NCT04788758	Hematopoietic a... Malignant Solid...	Educational Int... Screening Quest... Referral Questionnaire A...	-	Thomas Jefferson University
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy	NCT03080883	Cerebral Vein T... Deep Vein Throm... Hematopoietic a... Malignant Solid... Metastatic Mali... Pulmonary Embol... Splanchnic Vein...	Apixaban	18 Years -	Academic and Community Cancer Research United
Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic	NCT05102656	COVID-19 Infect... Hematopoietic a... Malignant Solid...	Best Practice Discussion Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors	NCT02496208	Bladder Small C... Bladder Squamou... Bladder Urothel... Clear Cell Rena... Invasive Bladde... Invasive Bladde... Invasive Sarcom... Kidney Medullar... Malignant Genit... Malignant Solid... Penile Carcinom... Penile Squamous... Renal Cell Carc... Renal Pelvis Ur... Sarcomatoid Ren... Stage III Bladd... Stage III Penil... Stage III Renal... Stage III Renal... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IV Bladde... Stage IV Penile... Stage IV Renal ... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Ureter Urotheli... Urethral Urothe...	Biopsy Biospecimen Col... Cabozantinib S-... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )	NCT05790538	Hematopoietic a... Malignant Solid...	Assessment of T... Electronic Heal... Medical Device ... Medical Device ... Survey Administ...	40 Years - 85 Years	OHSU Knight Cancer Institute
Cancer Genetic Testing in Ethnic Populations	NCT04475640	Breast Carcinom... Carcinoma of Un... Central Nervous... Digestive Syste... Genitourinary S... Head and Neck C... Malignant Brain... Malignant Femal... Malignant Muscu... Malignant Solid... Skin Carcinoma	Biospecimen Col... Genetic Testing	18 Years -	Mayo Clinic
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)	NCT05600556	Hematopoietic a... Malignant Solid...	Magnetic Resona... Computed Tomogr... Best Practice Questionnaire A... Magnetic Resona... Computed Tomogr... Virtual Technol... Questionnaire A...	18 Years -	Thomas Jefferson University
Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Chemotherapy	NCT04829539	Hematopoietic a... Malignant Solid...	Behavioral Inte... Behavioral Inte... Quality-of-Life... Questionnaire A...	18 Years -	University of Rochester
Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy	NCT05411523	Chemotherapy-In... Hematopoietic a... Malignant Solid...	Quality-of-Life... Questionnaire A... Spinal Cord Sti...	18 Years -	Mayo Clinic
Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease	NCT05515692	Hematopoietic a... Malignant Solid... Refractory Scle...	Biospecimen Col... Computed Tomogr... Electron Beam T... High Frequency ... Questionnaire A... Radiation Thera... Skin Biopsy	18 Years -	City of Hope Medical Center
Biomarkers to Predict Cancer Therapy-related Cardiotoxicity	NCT06353191	Hematopoietic a... Malignant Solid...	Non-Interventio...	18 Years -	Mayo Clinic
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method	NCT05054413	Hematopoietic a... Malignant Solid...	Questionnaire A...	21 Years -	M.D. Anderson Cancer Center
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers	NCT04459273	Bladder Carcino... Cervical Carcin... Cholangiocarcin... Hematopoietic a... Hepatocellular ... Malignant Adren... Malignant Brain... Malignant Pleur... Malignant Skin ... Malignant Solid... Malignant Testi... Malignant Thymu... Neuroendocrine ... Thyroid Gland C... Urothelial Carc... Cancer of Unkno...	Computed Tomogr... Gallium Ga 68 F... Positron Emissi... 18F-FDG	18 Years -	Jonsson Comprehensive Cancer Center
Patient Registry in Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound Imaging	NCT05717101	Hematopoietic a... Malignant Solid...	Electronic Heal...	18 Years - 99 Years	Mayo Clinic
Project: Every Child for Younger Patients With Cancer	NCT02402244	Carcinoma In Si... Central Nervous... Childhood Immat... Childhood Lange... Childhood Matur... Congenital Meso... Desmoid Fibroma... Ganglioneuroma Lymphoprolifera... Malignant Solid... Melanocytic Neo... Myeloproliferat... Neuroendocrine ... Stromal Neoplas...	Cytology Specim... Medical Chart R...	- 25 Years	Children's Oncology Group
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors	NCT03750227	Malignant Solid... Metastatic Mali...	Conventional Su... Quality-of-Life... Questionnaire A... Stereotactic Ra...	18 Years -	Mayo Clinic
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach	NCT04902144	Breast Carcinom... Colon Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin...	Electronic Heal... Questionnaire A... Behavioral Inte...	19 Years - 90 Years	Fred Hutchinson Cancer Center
Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer	NCT05075759	Hematopoietic a... Malignant Solid...	Behavioral Inte... Behavioral Inte... Behavioral Inte... Survey Administ...	18 Years - 54 Years	Fred Hutchinson Cancer Center
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN	NCT04983901	Hematopoietic a... Malignant Solid...	Imipenem/Cilast... Cefepime Meropenem Piperacillin-Ta... Vancomycin Daptomycin Linezolid	18 Years -	M.D. Anderson Cancer Center
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies	NCT02706392	Hematopoietic a... Malignant Solid... Metastatic Lung... Metastatic Trip... Recurrent Acute... Recurrent Mantl... Refractory Chro... Stage III Lung ... Stage IIIA Lung... Stage IIIB Lung... Stage IV Breast... Stage IV Lung N... Unresectable Lu...	Laboratory Biom... ROR1 CAR-specif...	18 Years -	Fred Hutchinson Cancer Center
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion	NCT06184321	Hematopoietic a... Malignant Solid...	Alteplase Placebo Adminis...	18 Years -	M.D. Anderson Cancer Center
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer	NCT05228275	COVID-19 Infect... Hematopoietic a... Malignant Solid...	Biospecimen Col... Survey Administ...	6 Months - 37 Years	Children's Oncology Group
Development of the Oncology Opportunity Cost Assessment Tool	NCT04694911	Hematopoietic a... Malignant Solid...	Focus Group Interview Research or Cli...	18 Years -	Thomas Jefferson University
Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors	NCT03878095	Malignant Solid... Refractory Chol... Refractory Mali...	Biopsy Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Ceralasertib Computed Tomogr... Magnetic Resona... Olaparib	18 Years -	National Cancer Institute (NCI)
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology	NCT02847130	Acute Lymphobla... B-Cell Non-Hodg... Childhood Acute... Childhood Burki... Childhood Neopl... Hematopoietic a... Malignant Solid... Recurrent Child...	Informational I... Interview Medical Chart R... Questionnaire A...	- 20 Years	Children's Oncology Group
Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma	NCT01989585	Clinical Stage ... Clinical Stage ... Malignant Solid... Metastatic Mela... Unresectable Me...	Biopsy Biospecimen Col... Computed Tomogr... Dabrafenib Echocardiograph... Laboratory Biom... Magnetic Resona... Multigated Acqu... Navitoclax Pharmacological... Trametinib	18 Years -	National Cancer Institute (NCI)
A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)	NCT06192875	Hematopoietic a... Malignant Solid...	Non-Interventio...	18 Years -	Mayo Clinic
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas	NCT03449108	Bone Sarcoma Dedifferentiate... Giant Cell Tumo... Malignancy in G... Malignant Solid... Ovarian Carcino... Platinum-Resist... Poorly Differen... Recurrent Osteo... Recurrent Ovari... Refractory Oste... Soft Tissue Sar... Thyroid Gland A... Thyroid Gland S... Undifferentiate... Triple Negative...	Aldesleukin Autologous Tumo... Autologous Tumo... Cyclophosphamid... Fludarabine Ipilimumab Nivolumab Quality-of-Life... Questionnaire A...	16 Years - 70 Years	M.D. Anderson Cancer Center
Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment	NCT04788758	Hematopoietic a... Malignant Solid...	Educational Int... Screening Quest... Referral Questionnaire A...	-	Thomas Jefferson University
Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy	NCT04170075	Chemotherapy-In... Hematopoietic a... Malignant Solid...	Whole Body Vibr...	18 Years -	OHSU Knight Cancer Institute
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy	NCT06414278	Hematopoietic a... Malignant Solid...	Non-Interventio...	18 Years -	Masonic Cancer Center, University of Minnesota
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial	NCT06022965	Hematopoietic a... Malignant Solid...	Best Practice Comprehensive G... Electronic Heal... Questionnaire A... Supportive Care Telemedicine	65 Years -	City of Hope Medical Center
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction	NCT06306638	Malignant Solid...	Biospecimen Col... Computed Tomogr... Endobronchial U... Interstitial Ph... Palliative Radi... Physical Perfor... Questionnaire A... Verteporfin	18 Years -	Roswell Park Cancer Institute
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis	NCT04438382	Hematopoietic a... Malignant Solid... Steroid-Refract...	Infliximab Intravenous Imm... Prednisone Methylprednisol...	18 Years -	Eastern Cooperative Oncology Group
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method	NCT05054413	Hematopoietic a... Malignant Solid...	Questionnaire A...	21 Years -	M.D. Anderson Cancer Center
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer	NCT03223753	Carcinoma In Si... Hematopoietic a... Malignant Solid...	Educational Int... Internet-Based ... Internet-Based ... Laboratory Biom... Medical Device ... Quality-of-Life... Questionnaire A...	8 Years - 16 Years	Children's Oncology Group
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors	NCT02496208	Bladder Small C... Bladder Squamou... Bladder Urothel... Clear Cell Rena... Invasive Bladde... Invasive Bladde... Invasive Sarcom... Kidney Medullar... Malignant Genit... Malignant Solid... Penile Carcinom... Penile Squamous... Renal Cell Carc... Renal Pelvis Ur... Sarcomatoid Ren... Stage III Bladd... Stage III Penil... Stage III Renal... Stage III Renal... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IV Bladde... Stage IV Penile... Stage IV Renal ... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Ureter Urotheli... Urethral Urothe...	Biopsy Biospecimen Col... Cabozantinib S-... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, (DURVA+ Study)	NCT03907475	Malignant Solid...	Biopsy Biospecimen Col... Capecitabine Carboplatin Computed Tomogr... Durvalumab Echocardiograph... Gemcitabine Hyd... Nab-paclitaxel Paclitaxel Pegylated Lipos...	18 Years -	National Cancer Institute (NCI)
Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer	NCT05346692	Hematopoietic a... Malignant Solid...	Survey Administ... Interview Text Message-Ba... Interview	18 Years -	Emory University
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization	NCT04439006	Aplastic Anemia Hematopoietic a... Malignant Solid... Monoclonal B-Ce... Monoclonal Gamm... Myelodysplastic... Symptomatic COV...	Best Practice Ibrutinib	18 Years -	Ohio State University Comprehensive Cancer Center
The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer	NCT05023993	Hematopoietic a... Malignant Solid... Prediabetes	Exercise Interv... Nicotinamide Ri...	18 Years -	City of Hope Medical Center
Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors	NCT04754529	Hematopoietic a... Malignant Solid...	Quality-of-Life... Survey Administ... Yoga	18 Years -	Roswell Park Cancer Institute
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax	NCT05092373	Advanced Breast... Advanced Endome... Advanced Fallop... Advanced Hepato... Advanced Malign... Advanced Malign... Advanced Malign... Advanced Ovaria... Advanced Primar... Advanced Renal ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Malignant Abdom... Malignant Solid... Metastatic Brea... Metastatic Endo... Metastatic Fall... Metastatic Hepa... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Ovar... Metastatic Prim... Metastatic Rena... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Fallo... Stage III Hepat... Stage III Ovari... Stage III Prima... Stage III Renal... Stage III Uteri... Stage IIIA Fall... Stage IIIA Hepa... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA Uter... Stage IIIA1 Fal... Stage IIIA1 Ova... Stage IIIA2 Fal... Stage IIIA2 Ova... Stage IIIB Fall... Stage IIIB Hepa... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIB Uter... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Fallop... Stage IV Hepato... Stage IV Ovaria... Stage IV Primar... Stage IV Renal ... Stage IV Uterin... Stage IVA Fallo... Stage IVA Hepat... Stage IVA Ovari... Stage IVA Prima... Stage IVA Uteri... Stage IVB Fallo... Stage IVB Hepat... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri...	Atezolizumab Cabozantinib S-... Nab-paclitaxel Tumor Treating ...	18 Years -	M.D. Anderson Cancer Center
Viral Specific T Cell Therapy for COVID-19 Related Pneumonia	NCT04742595	Hematopoietic a... Malignant Solid... Symptomatic COV...	SARS-CoV-2 Anti...	18 Years -	M.D. Anderson Cancer Center
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients	NCT05711667	Hematopoietic a... Malignant Solid...	Biospecimen Col... Letermovir	2 Years - 18 Years	Children's Oncology Group
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study	NCT04593277	Clinical Stage ... Clinical Stage ... Clinical Stage ... Hematopoietic a... Invasive Malign... Leukemia Lymphoma Malignant Solid... Sarcoma Stage I Colorec... Stage II Colore... Stage III Color... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Thyroid Gland C...	Internet Mobile... Internet-Based ... Questionnaire A... Supportive Care Informational I...	18 Years -	Fred Hutchinson Cancer Center
Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain	NCT04296305	Hematopoietic a... Malignant Solid...	Hydromorphone Placebo Adminis... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors	NCT05584449	Hematopoietic a... Malignant Solid...	Counseling Discussion Informational I... Medical Chart R... Quality-of-Life... Questionnaire A...	18 Years - 39 Years	Mayo Clinic
Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work	NCT05038384	Hematopoietic a... Malignant Solid...	Survey Administ...	-	M.D. Anderson Cancer Center
Project: Every Child for Younger Patients With Cancer	NCT02402244	Carcinoma In Si... Central Nervous... Childhood Immat... Childhood Lange... Childhood Matur... Congenital Meso... Desmoid Fibroma... Ganglioneuroma Lymphoprolifera... Malignant Solid... Melanocytic Neo... Myeloproliferat... Neuroendocrine ... Stromal Neoplas...	Cytology Specim... Medical Chart R...	- 25 Years	Children's Oncology Group
Virtual Reality Experiences for Anxiety and Pain Control	NCT04759183	Hematopoietic a... Malignant Solid...	Survey Administ... Virtual Reality... Virtual Reality...	18 Years - 89 Years	OHSU Knight Cancer Institute
Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )	NCT05790538	Hematopoietic a... Malignant Solid...	Assessment of T... Electronic Heal... Medical Device ... Medical Device ... Survey Administ...	40 Years - 85 Years	OHSU Knight Cancer Institute
Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer	NCT04555837	Head and Neck S... Malignant Solid...	Alisertib Pembrolizumab	18 Years -	M.D. Anderson Cancer Center
Weighted Blanket Use to Reduce Anxiety in Oncology Patients	NCT06089408	Hematopoietic a... Malignant Solid...	Best Practice Supportive Care Survey Administ...	18 Years -	Ohio State University Comprehensive Cancer Center
Transcutaneous Sensors for the Detection of Cancer-Related Lymphedema, Project Limb Rescue Study	NCT06305884	Hematopoietic a... Lymphedema Malignant Solid...	Bioelectric Imp... Exercise Photoplethysmog... Questionnaire A...	18 Years - 90 Years	Ohio State University Comprehensive Cancer Center
Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome	NCT04565665	COVID-19 Infect... COVID-19-Associ... Hematopoietic a... Malignant Solid... Symptomatic COV...	Best Practice Mesenchymal Ste...	18 Years -	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: